Related Experiment Videos
Persistent pulmonary hypertension of the newborn. Rational therapy based on pathophysiology
1Department of Pediatrics, Case Western Reserve University, Neonatal Intensive Care Unit, Cleveland, Ohio, USA.
Clinics in Perinatology
|September 26, 2001
Summary
Persistent pulmonary hypertension of the newborn (PPHN) is a common, severe condition in newborns. Current therapies for PPHN focus on understanding its pathophysiology to improve hypoxemia management.
Area of Science:
- Neonatology
- Pediatric Cardiology
- Respiratory Medicine
Background:
- Persistent pulmonary hypertension of the newborn (PPHN) is a significant clinical problem affecting near-term infants.
- PPHN often presents with hypoxemia that is resistant to standard treatments.
Purpose of the Study:
- To elucidate the pathophysiologic mechanisms underlying PPHN.
- To outline current therapeutic strategies for PPHN informed by its pathophysiology.
Main Methods:
- Review of existing literature on PPHN pathophysiology.
- Analysis of current clinical management guidelines for PPHN.
Main Results:
- Detailed explanation of the pathophysiologic basis of PPHN.
- Description of contemporary treatments tailored to the disorder's mechanisms.
Conclusions:
- Understanding PPHN pathophysiology is crucial for effective treatment.
- Current PPHN therapies are guided by pathophysiologic insights to manage refractory hypoxemia.